These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26214365)

  • 1. Dynamics and Membrane Interactions of Protein Kinase C.
    Igumenova TI
    Biochemistry; 2015 Aug; 54(32):4953-68. PubMed ID: 26214365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase C regulatory domains: the art of decoding many different signals in membranes.
    Corbalán-García S; Gómez-Fernández JC
    Biochim Biophys Acta; 2006 Jul; 1761(7):633-54. PubMed ID: 16809062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple pathways control protein kinase C phosphorylation.
    Parekh DB; Ziegler W; Parker PJ
    EMBO J; 2000 Feb; 19(4):496-503. PubMed ID: 10675318
    [No Abstract]   [Full Text] [Related]  

  • 4. The potential for isoenzyme-selective modulation of protein kinase C.
    Hofmann J
    FASEB J; 1997 Jul; 11(8):649-69. PubMed ID: 9240967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the cys2 activator-binding domain of protein kinase C delta in complex with phorbol ester.
    Zhang G; Kazanietz MG; Blumberg PM; Hurley JH
    Cell; 1995 Jun; 81(6):917-24. PubMed ID: 7781068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of the C1A and C1B domains to the membrane interaction of protein kinase C.
    Giorgione J; Hysell M; Harvey DF; Newton AC
    Biochemistry; 2003 Sep; 42(38):11194-202. PubMed ID: 14503869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling and site-directed mutagenesis studies of a phorbol ester-binding site in protein kinase C.
    Wang S; Kazanietz MG; Blumberg PM; Marquez VE; Milne GW
    J Med Chem; 1996 Jun; 39(13):2541-53. PubMed ID: 8691452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of the C2 domain from novel protein kinase Cepsilon. A membrane binding model for Ca(2+)-independent C2 domains.
    Ochoa WF; Garcia-Garcia J; Fita I; Corbalan-Garcia S; Verdaguer N; Gomez-Fernandez JC
    J Mol Biol; 2001 Aug; 311(4):837-49. PubMed ID: 11518534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isozyme-specific inhibitors and activators of protein kinase C.
    Schechtman D; Mochly-Rosen D
    Methods Enzymol; 2002; 345():470-89. PubMed ID: 11665630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase C - a family of protein kinases, allosteric effectors or both?
    Cameron AJ; Parker PJ
    Adv Enzyme Regul; 2010; 50(1):169-77. PubMed ID: 19914278
    [No Abstract]   [Full Text] [Related]  

  • 11. Modeling studies on the structural determinants for the DAG/phorbol ester binding to C1 domain.
    Rahman GM; Das J
    J Biomol Struct Dyn; 2015; 33(1):219-32. PubMed ID: 24666138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis of protein kinase C isoform function.
    Steinberg SF
    Physiol Rev; 2008 Oct; 88(4):1341-78. PubMed ID: 18923184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insights into C1-ligand interactions: Filling the gaps by in silico methods.
    Katti S; Igumenova TI
    Adv Biol Regul; 2021 Jan; 79():100784. PubMed ID: 33526356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro phosphorylation of insulin receptor substrate 1 by protein kinase C-zeta: functional analysis and identification of novel phosphorylation sites.
    Sommerfeld MR; Metzger S; Stosik M; Tennagels N; Eckel J
    Biochemistry; 2004 May; 43(19):5888-901. PubMed ID: 15134463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic manipulation of protein kinase C in vivo.
    Toker A
    Methods Mol Biol; 2003; 233():475-89. PubMed ID: 12840530
    [No Abstract]   [Full Text] [Related]  

  • 16. Nerve growth factor stimulates multisite tyrosine phosphorylation and activation of the atypical protein kinase C's via a src kinase pathway.
    Wooten MW; Vandenplas ML; Seibenhener ML; Geetha T; Diaz-Meco MT
    Mol Cell Biol; 2001 Dec; 21(24):8414-27. PubMed ID: 11713277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C pharmacology: refining the toolbox.
    Wu-Zhang AX; Newton AC
    Biochem J; 2013 Jun; 452(2):195-209. PubMed ID: 23662807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-associated protein kinase C mutations reveal kinase's role as tumor suppressor.
    Antal CE; Hudson AM; Kang E; Zanca C; Wirth C; Stephenson NL; Trotter EW; Gallegos LL; Miller CJ; Furnari FB; Hunter T; Brognard J; Newton AC
    Cell; 2015 Jan; 160(3):489-502. PubMed ID: 25619690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA class II-induced translocation of PKC alpha and PKC beta II isoforms is abrogated following truncation of DR beta cytoplasmic domains.
    Rich T; Lawler SE; Lord JM; Blancheteau VM; Charron DJ; Mooney NA
    J Immunol; 1997 Oct; 159(8):3792-8. PubMed ID: 9378966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory domain of human protein kinase C alpha dominantly inhibits protein kinase C beta-I-regulated growth and morphology in Saccharomyces cerevisiae.
    Parissenti AM; Kim SA; Colantonio CM; Snihura AL; Schimmer BP
    J Cell Physiol; 1996 Mar; 166(3):609-17. PubMed ID: 8600165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.